RT Journal Article
T1 Effect of previous anticoagulant treatment on risk of COVID-19
A1 Zapata Cachafeiro, Maruxa
A1 Prieto Campo, Ángela
A1 Portela Romero, Manuel
A1 Carracedo Martínez, Eduardo
A1 Lema Oreiro, Martina
A1 Piñeiro Lamas, María
A1 Chaudhuri, Somnath
A1 Salgado Barreira, Ángel
A1 Figueiras Guzmán, Adolfo
AB Introduction: Little is known about the role played by anticoagulants in COVID-19. Objective: The aim of this study was to assess the impact of previous anticoagulant treatment on risk of hospitalization due to COVID-19, progression to severe COVID-19 and susceptibility to COVID-19 infection. Methods: We conducted a multiple population-based case–control study in northwest Spain, in 2020, to assess (1) risk of hospitalization: cases were all patients admitted due to COVID-19 with PCR confirmation, and controls were a random matched sample of subjects without a positive PCR; (2) progression: cases were hospitalized COVID-19 subjects, and controls were all non-hospitalized COVID-19 patients; and (3) susceptibility: cases were patients with a positive PCR (hospitalized and non-hospitalized), and the controls were the same as for the hospitalization model. Adjusted odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated using a generalized linear mixed model
PB Springer
SN 0114-5916
YR 2022
FD 2022
LK http://hdl.handle.net/10347/29998
UL http://hdl.handle.net/10347/29998
LA eng
NO Zapata-Cachafeiro, M., Prieto-Campo, Á., Portela-Romero, M. et al. Effect of Previous Anticoagulant Treatment on Risk of COVID-19. Drug Saf (2022). https://doi.org/10.1007/s40264-022-01266-0
DS Minerva
RD 28 abr 2026